Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Centrum Medyczne ENEL-MED's annualizedNet Income for the quarter that ended in Mar. 2026 was zł3.9 Mil. Centrum Medyczne ENEL-MED's average total tangible assets for the quarter that ended in Mar. 2026 was zł624.8 Mil. Therefore, Centrum Medyczne ENEL-MED's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 0.62%.
The historical rank and industry rank for Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset or its related term are showing as below:
WAR:ENE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -5.65 Med: -0.36 Max: 2.92
Current: 1.33
During the past 13 years, Centrum Medyczne ENEL-MED's highest Return-on-Tangible-Asset was 2.92%. The lowest was -5.65%. And the median was -0.36%.
WAR:ENE's Return-on-Tangible-Asset is ranked worse than 57.06% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs WAR:ENE: 1.33
Centrum Medyczne ENEL-MED (WAR:ENE) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Centrum Medyczne ENEL-MED Return-on-Tangible-Asset Related Terms
Centrum Medyczne ENEL-MED Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Centrum Medyczne ENEL-MED Return-on-Tangible-Asset Chart
WAR:ENE vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centrum Medyczne ENEL-MED Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 0.62% mean?
Centrum Medyczne ENEL-MED (WAR:ENE) has a Return-on-Tangible-Asset of 0.62% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Centrum Medyczne ENEL-MED and its competitors. According to the industry distribution chart, Centrum Medyczne ENEL-MED ranks #388 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 57.1%.
Is Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset too high?
Centrum Medyczne ENEL-MED's current Return-on-Tangible-Asset is 0.62%. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. Centrum Medyczne ENEL-MED's value of 0.62% is 74.8% below this industry median. Based on the distribution chart, Centrum Medyczne ENEL-MED ranks #388 out of 680 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Centrum Medyczne ENEL-MED ranks #388 out of 680 companies for Return-on-Tangible-Asset. This places Centrum Medyczne ENEL-MED in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.47. Centrum Medyczne ENEL-MED's value of 0.62% is 74.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centrum Medyczne ENEL-MED's current Return-on-Tangible-Asset of 0.62% is 74.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Centrum Medyczne ENEL-MED and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centrum Medyczne ENEL-MED's current Return-on-Tangible-Asset is 0.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.33, compared to a current price of zł20.20 — trading 20.3% below its estimated fair value. The current Return-on-Tangible-Asset is 0.62% and 74.8% below the Healthcare Providers & Services industry median of 2.47. Centrum Medyczne ENEL-MED's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current Return-on-Tangible-Asset is 0.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued.
The current stock price of zł20.20 is trading 20.3% below its estimated GF Value™ of zł25.33.
GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.
Key valuation signals for WAR:ENE:
Return-on-Tangible-Asset: 0.62%
GF Value™: zł25.33 vs. price of zł20.20 (20.3% below fair value)
Industry Position: 74.8% below the Healthcare Providers & Services median (#388 of 680)
No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
76GF Score
Get the complete analysis for WAR:ENE
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ENE has been successfully added to your 
